TriLink BioTechnologies wins new China patent for CleanCap cap analog compounds

Maravai LifeSciences’ TriLink BioTechnologies won a new China patent covering CleanCap cap analog compounds used to make 5’-capped RNAs, with protection extending to RNAs containing the compounds, cells and drug products. Reuters via IG says a separate China patent on synthesis methods was issued months earlier.